Nitto Avecia
Sarah Hilderbrand is a highly experienced professional in quality control and research, currently serving as a Senior QC Data Reviewer at Nitto Denko Avecia Inc. since January 2021. Previous roles include Senior Quality Control Analyst and Operations Manager at EyePoint Pharmaceuticals, where responsibilities encompassed sample management and Incoming Quality Assurance. Sarah’s background also features project management at TriNetX, Inc., and clinical research coordination at Massachusetts General Hospital, alongside earlier positions in laboratory settings and academia. With a Master of Science in Inorganic Chemistry from the Massachusetts Institute of Technology and dual Bachelor's degrees in Chemistry and English Language and Literature from the University of Iowa, Sarah combines technical expertise with effective communication skills.
This person is not in the org chart
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.